Characterization of vancomycin-resistant enterococcus faecium isolated from swine in three michigan counties

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 4156-4160

  Donabedian, Susan M ^a   Perri, Mary Beth ^a   Abdujamilova, Nodira ^b   Gordoncillo, Mary Joy ^b   Naqvi, Amir ^b   Reyes, Katherine C ^a   Zervos, Marcus J ^a,c   Bartlett, Paul ^b  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; VANCOMYCIN;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CATTLE; ENTEROCOCCUS FAECIUM; FECES CULTURE; GOAT; HORSE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SHEEP; SWINE; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CAMELIDS, NEW WORLD; CARRIER STATE; CATTLE; CLUSTER ANALYSIS; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; FECES; GENOTYPE; GOATS; GRAM-POSITIVE BACTERIAL INFECTIONS; HORSES; HUMANS; MICHIGAN; MICROBIAL SENSITIVITY TESTS; SHEEP; SWINE; VANCOMYCIN; VANCOMYCIN RESISTANCE;

ANIMALIA; BOS; CAPRA HIRCUS; ENTEROCOCCUS FAECIUM; EQUIDAE; LAMA (MAMMAL); OVIS ARIES; SUIDAE;

EID: 78049505474     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02346-09     Document Type: Article

References (66)

1. Aarestrup, F. M. 1995. Occurrence of glycopeptide resistance among Enterococcus faecium isolated from conventional and ecological poultry farms. Microb. Drug Resist. 1:255-257.
2. Aarestrup, F. M., P. Ahrens, M. Madsen, L. V. Pallesen, R. L. Poulsen, and H. Westh. 1996. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob. Agents Chemother. 40:1938-1940.
3. Abele-Horn, M., U. Vogel, I. Klare, C. Konstabel, R. Trabold, R. Kurihara, W. Witte, W. Kreth, P. G. Schlegel, and H. Claus. 2006. Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci. J. Clin. Microbiol. 44:4009-4013.
4. Arthur, M., C. Molinas, F. Depardieu, and P. Courvalin. 1993. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:117-127.
5. Bager, F., M. Madsen, J. Christensen, and F. M. Aarestrup. 1997. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31:95-112.
6. Bates, J., J. Jordens, and D. T. Griffith. 1994. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infections in man. J. Antimicrob. Chemother. 34:507-516.
7. Camargo, I. L. B. C., M. S. Gilmore, and A. L. C. Darini. 2006. Multilocus sequence typing and analysis of putative factors in vancomycin-resistant Enterococcus faecium isolates from Brazil. Clin. Microbiol. Infect. 12:1123-1130.
8. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. J. Clin. Microbiol. 37:2311-2317.
9. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. CLSI M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Coque, T. M., J. F. Tomayko, S. C. Ricke, P. C. Okhyusen, and B. E. Murray. 1996. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. 40:2605-2609.
11. Coque, T. M., R. J. L. Willems, J. Fortún, J. Top, S. Diz, E. Loza, R. Cantón, and F. Baquero. 2005. Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob. Agents Chemother. 49:2693-2700.
12. De Leener, E., A. Martel, E. M. De Graef, J. Top, P. Butaye, F. Haesebrouck, R. Willems, and A. Decostere. 2005. Molecular analysis of human, porcine, and poultry Enterococcus faecium isolates and their erm (B) genes. Appl. Environ. Microbiol. 71:2766-2770.
13. Descheemaeker, P. R. M., S. Chapelle, L. A. Devriese, P. Butaye, P. Vandamme, and H. Goossens. 1999. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins. Antimicrob. Agents Chemother. 43:2032-2037.
14. Donabedian, S. M., J. W. Chow, D. M. Shlaes, M. Green, and M. J. Zervos. 1995. DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J. Clin. Microbiol. 33:141-145.
15. Donabedian, S., E. Hershberger, L. A. Thal, J. W. Chow, D. B. Clewell, B. Robinson-Dunn, and M. J. Zervos. 2000. PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium. J. Clin. Microbiol. 38:2885-2888.
16. Donabedian, S. M., L. A. Thal, E. Hershberger, M. B. Perri, J. W. Chow, P. Bartlett, R. Jones, K. Joyce, S. Rossiter, K. Gay, J. Johnson, C. Mackinson, E. DeBess, J. Madden, F. Angulo, and M. J. Zervos. 2003. Molecular characterization of gentamicin-resistant enterococci in the United States: evidence of spread from animals to humans through food. J. Clin. Microbiol. 41:1109-1113.
17. Donabedian, S. M., M. B. Perri, D. Vager, E. Hershberger, P. Malani, S. Simjee, J. Chow, E. N. Vergis, R. R. Muder, K. Gay, F. J. Angulo, P. Bartlett, and M. J. Zervos. 2006. Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States. J. Clin. Microbiol. 44:3361-3365.
18. Edmond, M. B., J. F. Ober, D. L. Weinbaum, M. A. Pfaller, T. Hwang, M. D. Sanford, and R. P. Wenzel. 1995. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 20:1126-1133.
19. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
20. Freitas, A. R., C. Novais, F. Baquero, T. M. Coque, and L. Peixe. 2009. International spread of vancomycin-resistant Enterococcus faecium (CC17, CC5) and Enterococcus faecalis CC2 among animals and humans, abstr. P-840. Abstr. 19th Eur. Congr. Clin. Microbiol. Infect. Dis., Helsinki, Finland.
21. Goossens, H., D. Jabes, R. Rossi, C. Lammens, G. Privitera, and P. Courvalin. 2003. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J. Antimicrob. Chemother. 51(Suppl. 3):5-12.
22. Hammerum, A. M., V. Fussing, F. M. Aarestrup, and H. C. Wegener. 2000. Characterization of vancomycin-resistant and vancomycin-susceptible Enterococcus faecium isolates from humans, chickens and pigs by RiboPrinting and pulsed-field gel electrophoresis. J. Antimicrob. Chemother. 45:677-680.
23. Hammerum, A. M., C. H. Lester, J. Neimann, L. J. Porsbo, K. E. P. Olsen, L. B. Jensen, H. D. Emborg, H. C. Wegener, and N. Frimodt-Moller. 2004. A vancomycin-resistant Enterococcus faecium isolate from a Danish healthy volunteer, detected 7 years after the ban of avoparcin, is possibly related to pig isolates. J. Antimicrob. Chemother. 53(Suppl. 3):547-549.
24. Handwerger, S., J. Skoble, L. F. Discotto, and M. J. Pucci. 1995. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrob. Agents Chemother. 39:362-368.
25. Handwerger, S., and Justin Skoble. 1995. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 39:2446-2453.
26. Hayes, J. R., A. C. McIntosh, S. Qaiyumi, J. A. Johnson, L. L. English, L. E. Carr, D. D. Wagner, and S. W. Joseph. 2001. High-frequency recovery of quinupristin-dalfopristin-resistant Enterococcus faecium isolates from the poultry production environment. J. Clin. Microbiol. 39:2298-2299.
27. Hayes, J. R., L. L. English, P. J. Carter, T. Proescholdt, K. Y. Lee, D. D. Wagner, and D. G. White. 2003. Prevalence and antimicrobial resistance of Enterococcus species isolated from retail meats. Appl. Environ. Microbiol. 69(12):7153-7160.
28. Hershberger, E., S. F. Oprea, S. M. Donabedian, M. Perri, P. Bozigar, P. Bartlett, and M. J. Zervos. 2005. Epidemiology of antimicrobial resistance in enterococci of animal origin. J. Antimicrob. Chemother. 55:127-130.
29. Hidron, A. I., J. R. Edwards, J. Patel, T. C. Horan, D. M. Sievert, D. A. Pollock, and S. K. Fridkin for the National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities. 2008. Antimicrobial- resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 9:996-1011.
30. Homan, W. L., D. Tribe, S. Poznanski, M. Li, G. Hogg, E. Spalburg, J. D. A. van Embden, and R. J. L. Willems. 2002. Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol. 40:1963-1971.
31. Jensen, L. B., P. Ahrens, L. Dons, R. N. Jones, A. M. Hammerum, and F. M. Aarestrup. 1998. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J. Clin. Microbiol. 36:437-442.
32. Jensen, L. B. 1998. Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs, and poultry. Antimicrob. Agents Chemother. 42:2463-2464.
33. Jensen, L. B., A. M. Hammerum, R. L. Poulsen, and H. Westh. 1999. Vancomycin- resistant Enterococcus faecium strains with highly similar pulsed- field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark. Antimicrob. Agents Chemother. 43:724-725.
34. Jones, M. E., D. C. Draghi, C. Thornsberry, J. A. Karlowsky, D. F. Sahm, and R. P. Wenzel. 2004. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American surveillance study (2000-2002). Ann. Clin. Microbiol. Antimicrob. 3:14.
35. Kirst, H. A., D. G. Thompson, and T. I. Nicas. 1998. Historical yearly usage of vancomycin. Antimicrob. Agents Chemother. 42:1303-1304.
36. Klare, I., H. Heier, H. Claus, G. Böhme, S. Marin, G. Seltmann, R. Hakenbeck, V. Antanassova, and W. Witte. 1995. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb. Drug Resist. 1:265-272.
37. Klare, I., C. Konstabel, S. Mueller-Bertling, G. Werner, B. Strommenger, C. Kettlitz, S. Borgmann, B. Schulte, D. Jonas, A. Serr, A. M. Fahr, U. Eigner, and W. Witte. 2005. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 24:815-825.
38. Ko, K. S., J. Y. Baek, J. Y. Lee, W. S. Oh, K. R. Peck, N. Y. Lee, W. G. Lee, K. Lee, and J. H. Song. 2005. Molecular characterization of vancomycinresistant Enterococcus faecium isolates from Korea. J. Clin. Microbiol. 43: 2303-2306.
39. Leavis, H., J. Top., N. Shankar, K. Borgen, M. Bonten, J. van Embden, and R. J. Willems. 2004. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J. Bacteriol. 186:672-682.
40. Mackinnon, M. G., M. A. Drebot, and G. J. Tyrrell. 1997. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. Antimicrob. Agents Chemother. 41:1805-1807.
41. Martinez, J. L., and F. Baquero. 2002. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 15:647-679.
42. McDonald, L. C., M. J. Kuehnert, F. C. Tenover, and W. R. Jarvis. 1997. Vancomycin-resistant enterococci outside the health care setting: prevalence, sources, and public health. Emerg. Infect. Dis. 3:311-317.
43. McDonald, L. C., S. Rossiter, C. MacKinson, Y. Y. Wang, S. Johnson, M. Sullivan, R. Sokolow, E. DeBess, L. Gilbert, J. A. Benson, B. Hill, and F. J. Angulo. 2001. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N. Engl. J. Med. 345:1155-1160.
44. Murray, B. E. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721.
45. Nallapareddy, S. R., K. V. Singh, P. C. Okhuysen, and B. E. Murray. 2008. A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect. Immun. 76:4110-4119.
46. Novais, C., J. C. Sousa, T. M. Coque, L. V. Peixe, and the Portuguese Resistance Study Group. 2005. Molecular characterization of glycopeptide- resistant Enterococcus faecium isolates from Portuguese hospitals. Antimicrob. Agents Chemother. 49:3073-3079.
47. Novais, C., T. M. Coque, P. Boerlin, I. Herrero, M. A. Moreno, L. Dominguez, and L. Peixe. 2005. Vancomycin-resistant Enterococcus faecium clone in swine, Europe. Emerg. Infect. Dis. 11:1985-1987.
48. Poole, T. L., M. E. Hume, L. D. Campbell, H. M. Scott, W. Q. Alali, and R. B. Harvey. 2005. Vancomycin-resistant Enterococcus faecium strains isolated from community wastewater from a semiclosed agri-food system in Texas. Antimicrob. Agents Chemother. 49:4382-4385.
49. Rice, L. B., L. Carias, S. Rudin, C. Vael, H. Goossens, C. Konstabel, I. Klare, S. R. Nallapareddy, W. Huang, and B. E. Murray. 2003. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J. Infect. Dis. 187:508-512.
50. Shankar, V., A. S. Baghdayan, M. M. Huycke, G. Lindahl, and M. S. Gilmore. 1999. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect. Immun. 67:193-200.
51. Simjee, S., D. G. White, D. D. Wagner, J. Meng, S. Qaiyumi, S. Zhao, and P. F. McDermott. 2002. Identification of vat(E) in Enterococcus faecalis isolates from retail poultry and its transferability to Enterococcus faecium. Antimicrob. Agents Chemother. 46:3823-3828.
52. Simjee, S., D. G. White, P. F. McDermott, D. D. Wagner, M. J. Zervos, S. M. Donabedian, L. L. English, J. R. Hayes, and R. D. Walker. 2002. Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci. J. Clin. Microbiol. 40:4659-4665.
53. Stobberingh, E., A. van den Bogaard, N. London, C. Driessen, J. Top, and R. Willems. 1999. Enterococci with glycopeptide resistance in turkeys, turkey farmers, and turkey slaughterers, and (sub)urban residents in the south of the Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob. Agents Chemother. 43:2215-2221.
54. Teixeira, L. M., M. G. S. Carvalho, and R. R. Facklam. 2007. Enterococcus, p. 430-442. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
55. Reference deleted.
56. van den Bogaard, A. E., L. B. Jensen, and E. E. Stobberingh. 1997. Vancomycin- resistant enterococci in turkeys and farmers. N. Engl. J. Med. 337: 1558-1559.
57. Van den Braak, N., A. van Belkum, M. van Keulen, J. Vliegenthart, H. A. Verbrugh, and H. P. Endtz. 1998. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in the Netherlands. J. Clin. Microbiol. 36:1927-1932.
58. Vankerckhoven, V., T. Van Autgaerden, C. Vael, C. Lammens, S. Chapelle, R. Rossi, D. Jabes, and H. Goossens. 2004. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J. Clin. Microbiol. 42:4473-4479.
59. Wegener, H. C., F. M. Aarestrup, L. B. Jensen, A. M. Hammerum, and F. Bager. 1999. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg. Infect. Dis. 5:329-335.
60. Welton, L. A., L. A. Thal, M. B. Perri, S. M. Donabedian, J. McMahon, J. W. Chow, and M. J. Zervos. 1998. Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin. Antimicrob. Agents Chemother. 42:705-708.
61. Willems, R. J. L., J. Top, N. van den Braak, A. van Belkum, D. J. Mevius, G. Hendriks, M. van Santen-Verheuvel, and J. D. A. van Embden. 1999. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob. Agents Chemother. 43: 483-491.
62. Reference deleted.
63. Willems, R. J. L., W. Homan, J. Top, M. van Santen-Verheuvel, D. Tribe, X. Manzioros, C. Gaillard, C. M. J. E. Vandenbroucke-Grauls, E. M. Mascini, E. van Kregten, J. D. A. van Embden, and M. J. M. Bonten. 2001. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357:853-855.
64. Willems, R. J. L., J. Top, M. van Santen, D. A. Robinson, T. M. Coque, F. Baquero, H. Grundmann, and M. J. M. Bonten. 2005. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg. Infect. Dis. 11:821-828.
65. Woodford, N., A. M. A. Adebiyi, M. F. I. Palepou, and B. D. Cookson. 1998. Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob. Agents Chemother. 42:502-508.
66. Zirakzadeh, A., and R. Patel. 2006. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin. Proc. 81:529-536.